Protein-protein interactions between TNF and its receptor TNF-R1 are known to regulate the canonical TNF-induced NF-κB pathway and are therefore considered a pivotal therapeutic target for the treatment of TNF-associated autoimmune diseases, including cancer (10, 26, 27). The gene discussed is NFKB1; the disease is cancer.